Current overview of osteogenesis imperfecta
M Deguchi, S Tsuji, D Katsura, K Kasahara, F Kimura… - Medicina, 2021 - mdpi.com
Osteogenesis imperfecta (OI), or brittle bone disease, is a heterogeneous disorder
characterised by bone fragility, multiple fractures, bone deformity, and short stature. OI is a …
characterised by bone fragility, multiple fractures, bone deformity, and short stature. OI is a …
Reproductive options for families at risk of Osteogenesis Imperfecta: a review
L Zhytnik, K Simm, A Salumets, M Peters… - Orphanet journal of rare …, 2020 - Springer
Abstract Background Osteogenesis Imperfecta (OI) is a rare genetic disorder involving bone
fragility. OI patients typically suffer from numerous fractures, skeletal deformities, shortness …
fragility. OI patients typically suffer from numerous fractures, skeletal deformities, shortness …
Enrichment of circulating trophoblasts from maternal blood using filtration-based Metacell® technology
J Weymaere, AS Vander Plaetsen, Y Van Den Branden… - Plos one, 2022 - journals.plos.org
In a cell-based non-invasive prenatal test (cbNIPT), intact circulating trophoblasts (CTs) are
isolated from maternal blood for subsequent genetic analysis. Enrichment of these CTs from …
isolated from maternal blood for subsequent genetic analysis. Enrichment of these CTs from …
Development and validation of an expanded targeted sequencing panel for non-invasive prenatal diagnosis of sporadic skeletal dysplasia
CY Wang, YA Tang, IW Lee, FM Chang… - BMC Medical …, 2021 - Springer
Background Skeletal dysplasia (SD) is one of the most common inherited neonatal disorders
worldwide, where the recurrent pathogenic mutations in the FGFR2, FGFR3, COL1A1 …
worldwide, where the recurrent pathogenic mutations in the FGFR2, FGFR3, COL1A1 …
Simultaneous detection of fetal aneuploidy, de novo FGFR3 mutations and paternally derived β‐thalassemia by a novel method of noninvasive prenatal testing
L Yang, Y Wu, Z Hu, H Zhang, D Pu, H Yan… - Prenatal …, 2021 - Wiley Online Library
Objective The aim is to develop a novel noninvasive prenatal testing (NIPT) method that
simultaneously performs fetal aneuploidy screening and the detection of de novo and …
simultaneously performs fetal aneuploidy screening and the detection of de novo and …
[HTML][HTML] Prenatal identification of autism propensity
G Steinman - Medical Hypotheses, 2019 - Elsevier
The innovative method described involves antepartum testing to determine if the fetus has
the potential of later developing autism. A technique is detailed which allows examining the …
the potential of later developing autism. A technique is detailed which allows examining the …
Computational framework for targeted high-coverage sequencing based NIPT
Non-invasive prenatal testing (NIPT) enables accurate detection of fetal chromosomal
trisomies. The majority of publicly available computational methods for sequencing-based …
trisomies. The majority of publicly available computational methods for sequencing-based …
Impact of emerging technologies in prenatal genetic counseling
B Stevens - Cold Spring Harbor Perspectives in …, 2020 - perspectivesinmedicine.cshlp.org
For decades, prenatal testing has been offered to evaluate pregnancies for genetic
conditions. In recent years, the number of testing options and range of testing capabilities …
conditions. In recent years, the number of testing options and range of testing capabilities …
Relationship Between Gene-Phenotype and Clinical Manifestations of Chromosomal Copy Number Variations Indicated by Non-Invasive Prenatal Testing
Z Pi, X Duan, J Peng, Y Liu - Journal of Clinical and Nursing …, 2024 - ojs.bbwpublisher.com
Objective: To analyze the clinical value of non-invasive prenatal testing (NIPT) in detecting
chromosomal copy number variations (CNVs) and to explore the relationship between gene …
chromosomal copy number variations (CNVs) and to explore the relationship between gene …
Multi-Modality Plasma-Based Detection of Minimal Residual Disease in Triple-Negative Breast Cancer
YH Chen - 2019 - scholarworks.iupui.edu
Triple-negative breast cancers (TNBCs) are pathologically defined by the absence of
estrogen, progesterone, and HER2 receptors. Compared to other breast cancers, TNBC has …
estrogen, progesterone, and HER2 receptors. Compared to other breast cancers, TNBC has …